Alopécie Areata : Traitement en l'Absence de 25 % de Repousse Pilaire après 12 Semaines de Corticoïdes Topiques

References

DOI: 10.14924/dermatol.134.2491

• However, considering clinical results in other countries, this therapy may be performed as a regimen of combination therapy.
• Furthermore, this therapy is not covered by health insurance, but it may be primarily performed in standard-type (solitary or multiple) AA patients as a regimen of combination therapy, considering the simple procedure and very mild adverse reactions.
• Considering coverage by health insurance and the safety secured by clinical results in Japan, oral cepharanthin therapy may be performed as a regimen of combination therapy in solitary and multiple AA patients.
• However, considering coverage by health insurance and the safety secured by clinical results in Japan, this therapy may be performed as a regimen of combination therapy in solitary and multiple AA patients.
• Considering coverage by health insurance and the long-term safety secured by clinical results in Japan, this therapy may be performed as a regimen of combination therapy in mild solitary and multiple AA patients.
• Therefore, oral antihistamine therapy may be performed as a regimen of combination therapy to obtain atopic predisposition-improving effects in AA patients with atopic predispositions.